GBM Immunotherapy: Macrophage Impacts

References

• Akkari, L., Bowman, R. L., Tessier, J., Klemm, F., Handgraaf, S. M., de Groot, M., Quail, D. F., Tillard, L., Gadiot, J., Huse, J. T., Brandsma, D., Westerga, J., Watts, C., & Joyce, J. A. (2020). Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Science Translational Medicine, 12(552), 7843–7843. https://doi.org/10.1126/scitranslmed.aaw7843
   Web of Science ®Google Scholar
• Anghileri, E., Patane, M., Di, I. N., Sambruni, I., Maffezzini, M., Milani, M., Maddaloni, L., Pollo, B., Eoli, M., & Pellegatta, S. (2021). Deciphering the labyrinthine system of the immune microenvironment in recurrent glioblastoma: recent original advances and lessons from clinical immunotherapeutic approaches. Cancers (Basel), 13(24), 13. https://doi.org/10.3390/cancers13246156
   Web of Science ®Google Scholar
• Bai, Y., Lathia, J. D., Zhang, P., Flavahan, W., Rich, J. N., & Mattson, M. P. (2014). Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells. Glia, 62(10), 1687–1698. https://doi.org/10.1002/glia.22708
   PubMed Web of Science ®Google Scholar
• Baker, K. (2018). Organoids provide an important window on inflammation in cancer. Cancers, 10(5), 151. https://doi.org/10.3390/cancers10050151
   PubMed Web of Science ®Google Scholar
• Benner, B., Good, L., Quiroga, D., Schultz, T. E., Kassem, M., Carson, W. E., Cherian, M. A., Sardesai, S., & Wesolowski, R. (2020). Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: A systematic review of pre-clinical and clinical development. Drug Design, Development and Therapy, 14, 1693–1704. https://doi.org/10.2147/DDDT.S253232
   PubMed Web of Science ®Google Scholar
• Buonfiglioli, A., & Hambardzumyan, D. (2021). Macrophages and microglia: The cerberus of glioblastoma. Acta neuropathologica communications, 9(1), 54. https://doi.org/10.1186/s40478-021-01156-z
   PubMed Web of Science ®Google Scholar
• Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., Huse, J., Phillips, J., West, B. L., Nolop, K. B., Hsu, H. H., Ligon, K. L., Molinaro, A. M., & Prados, M. (2016). Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An ivy foundation early phase clinical trials consortium phase II study. Neuro-Oncology, 18(4), 557–564. https://doi.org/10.1093/neuonc/nov245
   PubMed Web of Science ®Google Scholar
• Cannarile, M. A., Weisser, M., Jacob, W., Jegg, A. M., Ries, C. H., & Ruttinger, D. (2017). Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. The Journal for ImmunoTherapy of Cancer, 5(1), 53. https://doi.org/10.1186/s40425-017-0257-y
   PubMedGoogle Scholar
• Cersosimo, F., Lonardi, S., Ulivieri, C., Martini, P., Morrione, A., Vermi, W., Giordano, A., & Giurisato, E. (2024). CSF-1R in cancer: More than a myeloid cell receptor. Cancers, 16(2), 282. https://doi.org/10.3390/cancers16020282
   PubMed Web of Science ®Google Scholar
• Chen, P., DePinho, R., Alan, W., Liang, X., Li, J., Chang, A., Henry, V. K., Lan, Z., Spring, D. J., Rao, G., Wang, Y. A., & DePinho, R. A. (2019). Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-null Glioma. Neuro-Oncology, 35(6), 868–884. https://doi.org/10.1016/j.ccell.2019.05.003
   Google Scholar
• Chen, Z., Feng, X., Herting, C. J., Garcia, V. A., Nie, K., Pong, W. W., Rasmussen, R., Dwivedi, B., Seby, S., Wolf, S. A., Gutmann, D. H., & Hambardzumyan, D. (2017). Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Research, 77(9), 2266–2278. https://doi.org/10.1158/0008-5472.CAN-16-2310
   PubMed Web of Science ®Google Scholar
• Chen, J., Fu, X., Wan, Y., Wang, Z., Jiang, D., & Shi, L. (2014). miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1. Tumor Biology, 35(7), 6293–6302. https://doi.org/10.1007/s13277-014-1821-4
   PubMedGoogle Scholar
• Chen, X., Gao, A., Zhang, F., Yang, Z., Wang, S., Fang, Y., Li, J., Wang, J., Shi, W., Wang, L., Zheng, Y., & Sun, Y. (2021). ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics, 11(7), 3392–3416. https://doi.org/10.7150/thno.52435
   PubMed Web of Science ®Google Scholar
• Chen, A. X., Gartrell, R. D., Zhao, J., Upadhyayula, P. S., Zhao, W., Yuan, J., Minns, H. E., Dovas, A., Bruce, J. N., Lasorella, A., Iavarone, A., Canoll, P., Sims, P. A., & Rabadan, R. (2021). Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker. Genome Medicine, 13(1), 88. https://doi.org/10.1186/s13073-021-00906-x
   PubMed Web of Science ®Google Scholar
• Cheng, P., Ma, Y., Gao, Z., & Duan, L. (2018). High mobility group box 1 (HMGB1) predicts invasion and poor prognosis of glioblastoma multiforme via activating AKT signaling in an autocrine pathway. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 24, 8916–8924. https://doi.org/10.12659/MSM.912104
   PubMed Web of Science ®Google Scholar
• Chen, P., Hsu, W. H., Han, J., Xia, Y., & DePinho, R. A. (2021). Cancer stemness meets immunity: From mechanism to therapy. Cell Reports, 34(1), 108597. https://doi.org/10.1016/j.celrep.2020.108597
   PubMed Web of Science ®Google Scholar
• Chitu, V., Gokhan, Ş., Nandi, S., Mehler, M. F., & Stanley, E. R. (2016). Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends in neurosciences, 39(6), 378–393. https://doi.org/10.1016/j.tins.2016.03.005
   PubMed Web of Science ®Google Scholar
• Choi, J., Mai, N., Jackson, C., Belcaid, Z., & Lim, M. (2018). It takes two: Potential therapies and insights involving microglia and macrophages in glioblastoma. Neuroimmunology and Neuroinflammation, 5(10), 42–42. https://doi.org/10.20517/2347-8659.2018.47
   Google Scholar
• Cisneros Castillo, L. R., Oancea, A. D., Stullein, C., & Regnier-Vigouroux, A. (2016). A novel computer-assisted approach to evaluate multicellular tumor spheroid invasion assay. Scientific Reports, 6(1), 35099. https://doi.org/10.1038/srep35099
   PubMedGoogle Scholar
• Codrici, E., Popescu, I. D., Tanase, C., & Enciu, A. M. (2022). Friends with benefits: Chemokines, glioblastoma-associated microglia/macrophages, and tumor microenvironment. International Journal of Molecular Sciences, 23(5), 2509. https://doi.org/10.3390/ijms23052509
   PubMed Web of Science ®Google Scholar
• Cohen, J. V., & Kluger, H. M. (2016). Systemic immunotherapy for the treatment of brain metastases. Frontiers in Oncology, 6, 49. https://doi.org/10.3389/fonc.2016.00049
   PubMed Web of Science ®Google Scholar
• Coniglio, S. J., Eugenin, E., Dobrenis, K., Stanley, E. R., West, B. L., Symons, M. H., & Segall, J. E. (2012). Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Molecular Medicine (Cambridge, Mass), 18(3), 519–527. https://doi.org/10.2119/molmed.2011.00217
   PubMed Web of Science ®Google Scholar
• Costa, P. M., Cardoso, A. L., Custodia, C., Cunha, P., de Almeida, L. P., & Pedroso de Lima, M. C. (2015). MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. Journal of Controlled Release, 207, 31–39. https://doi.org/10.1016/j.jconrel.2015.04.002
   PubMed Web of Science ®Google Scholar
• Cui, X., Morales, R. T., Qian, W., Wang, H., Gagner, J. P., Dolgalev, I., Placantonakis, D., Zagzag, D., Cimmino, L., Snuderl, M., Lam, R. H. W., & Chen, W. (2018). Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials, 161, 164–178. https://doi.org/10.1016/j.biomaterials.2018.01.053
   PubMed Web of Science ®Google Scholar
• Dai, X., Ye, L., Li, H., Dong, X., Tian, H., Gao, P., Dong, J., & Cheng, H. (2023). Crosstalk between microglia and neural stem cells influences the relapse of glioblastoma in GBM immunological microenvironment. Clinical Immunology (Orlando, Fla), 251, 109333. https://doi.org/10.1016/j.clim.2023.109333
   PubMed Web of Science ®Google Scholar
• Dammeijer, F., Lievense, L. A., Kaijen-Lambers, M. E., van Nimwegen, M., Bezemer, K., Hegmans, J. P., van Hall, T., Hendriks, R. W., & Aerts, J. G. (2017). Depletion of tumor-associated macrophages with a CSF-1R kinase inhibitor enhances antitumor immunity and survival induced by DC immunotherapy. Cancer Immunology Research, 5(7), 535–546. https://doi.org/10.1158/2326-6066.CIR-16-0309
   PubMed Web of Science ®Google Scholar
• Dapash, M., Hou, D., Castro, B., Lee-Chang, C., & Lesniak, M. S. (2021). The interplay between glioblastoma and its microenvironment. Cells, 10(9), 2257. https://doi.org/10.3390/cells10092257
   PubMed Web of Science ®Google Scholar
• Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S., Samghababi, P., Zhang, Y., Neff, N., Kowarsky, M., Caneda, C., Li, G., Chang, S. D., Connolly, I. D., Li, Y., Barres, B. A., Gephart, M. H., & Quake, S. R. (2017). Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Reports, 21(5), 1399–1410. https://doi.org/10.1016/j.celrep.2017.10.030
   PubMed Web of Science ®Google Scholar
• Delcassian, D., Malecka, A. A., Opoku, D., Cabeza, V. P., Merry, C., & Jackson, A. M. (2019). Primary human macrophages are polarized towards pro-inflammatory 1 phenotypes in alginate hydrogels. bioRxiv, 824391. https://doi.org/10.1101/824391
   Google Scholar
• DeNardo, D. G., & Ruffell, B. (2019). Macrophages as regulators of tumour immunity and immunotherapy. Nature Reviews Immunology, 19(6), 369–382. https://doi.org/10.1038/s41577-019-0127-6
   PubMed Web of Science ®Google Scholar
• DiModugno, F., Colosi, C., Trono, P., Antonacci, G., Ruocco, G., & Nistico, P. (2019). 3D models in the new era of immune oncology: Focus on T cells, CAF and ECM. Journal of Experimental and Clinical Cancer Research, 38(1), 117. https://doi.org/10.1186/s13046-019-1086-2
   PubMedGoogle Scholar
• Ding, A. S., Routkevitch, D., Jackson, C., & Lim, M. (2019). Targeting myeloid cells in combination treatments for glioma and other tumors. Frontiers in Immunology, 10, 1715–1715. https://doi.org/10.3389/fimmu.2019.01715
   PubMed Web of Science ®Google Scholar
• Dusoswa, S. A., Verhoeff, J., Abels, E., Méndez-Huergo, S. P., Croci, D. O., Kuijper, L. H., de Miguel, E., Wouters, V. M. C. J., Best, M. G., Rodriguez, E., Cornelissen, L. A. M., van Vliet, S. J., Wesseling, P., Breakefield, X. O., Noske, D. P., Würdinger, T., Broekman, M. L. D., Rabinovich, G. A., van Kooyk, Y., & Garcia-Vallejo, J. J. (2020). Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin. Proceedings of the National Academy of Sciences of the United States of America, 117(7), 3693–3703. https://doi.org/10.1073/pnas.1907921117
   PubMed Web of Science ®Google Scholar
• Fedele, M., Cerchia, L., Pegoraro, S., Sgarra, R., & Manfioletti, G. (2019). Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma. International Journal of Molecular Sciences, 20(11), 2746. https://doi.org/10.3390/ijms20112746
   PubMed Web of Science ®Google Scholar
• Flores-Toro, J. A., Luo, D., Gopinath, A., Sarkisian, M. R., Campbell, J. J., Charo, I. F., Singh, R., Schall, T. J., Datta, M., Jain, R. K., Mitchell, D. A., & Harrison, J. K. (2020). CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proceedings of the National Academy of Sciences of the United States of America, 117(2), 1129–1138. https://doi.org/10.1073/pnas.1910856117
   PubMed Web of Science ®Google Scholar
• Galluzzi, L., Vacchelli, E., Bravo-San Pedro, J. M., Buque, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., Apte, R. N., Aranda, F., Ayyoub, M., Beckhove, P., Blay, J.-Y., Bracci, L., Caignard, A., Castelli, C., … Zou, W. (2014). Classification of current anticancer immunotherapies. Oncotarget, 5(24), 12472–12508. https://doi.org/10.18632/oncotarget.2998
   PubMed Web of Science ®Google Scholar
• Gao, H., Yang, Z., Cao, S., Xiong, Y., Zhang, S., Pang, Z., & Jiang, X. (2014). Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials, 35(7), 2374–2382. https://doi.org/10.1016/j.biomaterials.2013.11.076
   PubMed Web of Science ®Google Scholar
• Garris, C. S., Blaho, V. A., Hla, T., & Han, M. H. (2014). Sphingosine-1-phosphate receptor 1 signalling in T cells: Trafficking and beyond. Immunology, 142(3), 347–353. https://doi.org/10.1111/imm.12272
   PubMed Web of Science ®Google Scholar
• Geraldo, L. H., Xu, Y., Jacob, L., Pibouin-Fragner, L., Rao, R., Maissa, N., Verreault, M., Lemaire, N., Knosp, C., Lesaffre, C., Daubon, T., Dejaegher, J., Solie, L., Rudewicz, J., Viel, T., Tavitian, B., De Vleeschouwer, S., Sanson, M., … Eichmann, A. (2021). SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia. Journal of Clinical Investigation, 131(16), e141083. https://doi.org/10.1172/JCI141083
   PubMed Web of Science ®Google Scholar
• Gholamin, S., Mitra, S. S., Feroze, A. H., Liu, J., Kahn, S. A., Zhang, M., Esparza, R., Richard, C., Ramaswamy, V., Remke, M., Volkmer, A. K., Willingham, S., Ponnuswami, A., McCarty, A., Lovelace, P., Storm, T. A., Schubert, S., Hutter, G., … Weissman, I. L. (2017). Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine, 9(381), eaaf2968. https://doi.org/10.1126/scitranslmed.aaf2968
   PubMed Web of Science ®Google Scholar
• Ginhoux, F., Lim, S., Hoeffel, G., Low, D., & Huber, T. (2013). Origin and differentiation of microglia. Frontiers in Cellular Neuroscience, 7, 45. https://doi.org/10.3389/fncel.2013.00045
   PubMed Web of Science ®Google Scholar
• Goenka, A., Tiek, D., Song, X., Huang, T., Hu, B., & Cheng, S. Y. (2021). The many facets of therapy resistance and tumor recurrence in glioblastoma. Cells, 10(3), 1–21. https://doi.org/10.3390/cells10030484
   Web of Science ®Google Scholar
• Gonzalez-Gomez, P., Anselmo, N. P., & Mira, H. (2014). BMPs as therapeutic targets and biomarkers in astrocytic glioma. BioMed Research International, 2014, 549742. https://doi.org/10.1155/2014/549742
   PubMed Web of Science ®Google Scholar
• Goswami, S., Walle, T., Cornish, A. E., Basu, S., Anandhan, S., Fernandez, I., Vence, L., Blando, J., Zhao, H., Yadav, S. S., Ott, M., Kong, L. Y., Heimberger, A. B., de Groot, J., Sepesi, B., Overman, M., Kopetz, S., Allison, J. P., Pe’er, D., & Sharma, P. (2020). Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nature Medicine, 26(1), 39–46. https://doi.org/10.1038/s41591-019-0694-x
   PubMed Web of Science ®Google Scholar
• Hartley, G., Regan, D., Guth, A., & Dow, S. (2017). Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α. Cancer Immunology, Immunotherapy: CII, 66(4), 523–535. https://doi.org/10.1007/s00262-017-1955-5
   PubMed Web of Science ®Google Scholar
• Held-Feindt, J., Hattermann, K., Muerkoster, S. S., Wedderkopp, H., Knerlich-Lukoschus, F., Ungefroren, H., Mehdorn, H. M., & Mentlein, R. (2010). CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Experimental Cell Research, 316(9), 1553–1566. https://doi.org/10.1016/j.yexcr.2010.02.018
   PubMed Web of Science ®Google Scholar
• Herter, S., Morra, L., Schlenker, R., Sulcova, J., Fahrni, L., Waldhauer, I., Lehmann, S., Reisländer, T., Agarkova, I., Kelm, J. M., Klein, C., Umana, P., & Bacac, M. (2017). A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents. Cancer Immunology Immunotherapy, 66(1), 129–140. https://doi.org/10.1007/s00262-016-1927-1
   PubMed Web of Science ®Google Scholar
• Himes, B. T., Geiger, P. A., Ayasoufi, K., Bhargav, A. G., Brown, D. A., & Parney, I. F. (2021). Immunosuppression in glioblastoma: Current understanding and therapeutic implications. Frontiers in Oncology, 11, 770561. https://doi.org/10.3389/fonc.2021.770561
   PubMed Web of Science ®Google Scholar
• Hutter, G., Theruvath, J., Graef, C. M., Zhang, M., Schoen, M. K., Manz, E. M., Bennett, M. L., Olson, A., Azad, T. D., Sinha, R., Chan, C., Assad Kahn, S., Gholamin, S., Wilson, C., Grant, G., He, J., Weissman, I. L., Mitra, S. S., & Cheshier, S. H. (2019). Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America, 116(3), 997–1006. https://doi.org/10.1073/pnas.1721434116
   PubMed Web of Science ®Google Scholar
• Jackson, C. M., Kochel, C. M., Nirschl, C. J., Durham, N. M., Ruzevick, J., Alme, A., Francica, B. J., Elias, J., Daniels, A., Dubensky, T. W., Lauer, P., Brockstedt, D. G., Baxi, E. G., Calabresi, P. A., Taube, J. M., Pardo, C. A., Brem, H., Pardoll, D. M., Lim, M., & Drake, C. G. (2016). Systemic tolerance mediated by melanoma brain tumors is reversible by radiotherapy and vaccination. Clinical Cancer Research, 22(5), 1161–1172. https://doi.org/10.1158/1078-0432.CCR-15-1516
   PubMed Web of Science ®Google Scholar
• Jarosz-Biej, M., Smolarczyk, R., Cichon, T., & Kułach, N. (2019). Tumor microenvironment as a “game changer” in cancer radiotherapy. International Journal of Molecular Sciences, 20(13), 3212. https://doi.org/10.3390/ijms20133212
   PubMed Web of Science ®Google Scholar
• Jung, J., Kim, L. J., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., & Rich, J. N. (2017). Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight, 2(10), e90019. https://doi.org/10.1172/jci.insight.90019
   PubMed Web of Science ®Google Scholar
• Khan, F., Pang, L., Dunterman, M., Lesniak, M. S., Heimberger, A. B., & Chen, P. (2023). Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy. The Journal of Clinical Investigation, 133(1), e163446. https://doi.org/10.1172/JCI163446
   PubMed Web of Science ®Google Scholar
• Kim, H., Cha, J., Jang, M., & Kim, P. (2019). Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte/macrophage. Biomaterials Science, 7(6), 2264–2271. https://doi.org/10.1039/C9BM00155G
   PubMed Web of Science ®Google Scholar
• Kreatsoulas, D., Bolyard, C., Wu, B. X., Cam, H., Giglio, P., & Li, Z. (2022). Translational landscape of glioblastoma immunotherapy for physicians: Guiding clinical practice with basic scientific evidence. Journal of Hematology and Oncology, 15(1), 80. https://doi.org/10.1186/s13045-022-01298-0
   PubMed Web of Science ®Google Scholar
• Kumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O., Tate, M., Schwartz, M., Zuckerman, L., Lezon, R., Lukas, R. V., Jovanovic, B., McCortney, K., Colman, H., Chen, S., Lai, B., Antipova, O., Deng, J., … Horbinski, C. (2021). A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma. Science Translational Medicine, 13(584), eabb3945. https://doi.org/10.1126/scitranslmed.abb3945
   PubMed Web of Science ®Google Scholar
• Kuppner, M. C., Hamou, M. F., Sawamura, Y., Bodmer, S., & de Tribolet, N. (1989). Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2. Journal of Neurosurgery, 71(2), 211–217. https://doi.org/10.3171/jns.1989.71.2.0211
   PubMed Web of Science ®Google Scholar
• Larsen, A. M. H., Kuczek, D. E., Kalvisa, A., Siersbæk, M. S., Thorseth, M. L., Johansen, A. Z., Carretta, M., Grøntved, L., Vang, O., & Madsen, D. H. (2020). Collagen density modulates the immunosuppressive functions of macrophages. Journal of Immunology, 205(5), 1461–1472. https://doi.org/10.4049/jimmunol.1900789
   PubMed Web of Science ®Google Scholar
• Lee, C., Kim, G. R., Yoon, J., Kim, S. E., Yoo, J. S., & Piao, Y. (2018). In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance. Scientific Reports, 8(1), 11122. https://doi.org/10.1038/s41598-018-29424-4
   PubMedGoogle Scholar
• Li, J., Kaneda, M. M., Ma, J., Chen, C. C., Shepard, R. M., Patel, K., Koga, T., Sarver, A., Furnari, F., Xu, B., Dhawan, S., Ning, J., Zhu, H., Wu, A., You, G., Jiang, T., Venteicher, A. S., Rich, J. N., … Varner, J. A. (2021). PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response. Proceedings of the National Academy of Sciences of the United States of America, 118(16), e2009290118. https://doi.org/10.1073/pnas.2009290118
   PubMed Web of Science ®Google Scholar
• Lin, J. G., Kang, C. C., Zhou, Y., Huang, H., Herr, A. E., & Kumar, S. (2018). Linking invasive motility to protein expression in single tumor cells. Lab on a Chip, 18(2), 371–384. https://doi.org/10.1039/C7LC01008G
   PubMed Web of Science ®Google Scholar
• Linville, R. M., Boland, N. F., Covarrubias, G., Price, G. M., & Tien, J. (2016). Physical and chemical signals that promote vascularization of capillary-scale channels. Cellular and Molecular Bioengineering, 9(1), 73–84. https://doi.org/10.1007/s12195-016-0429-8
   PubMed Web of Science ®Google Scholar
• Li, W., Wu, F., Zhao, S., Shi, P., Wang, S., & Cui, D. (2022). Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. Cytokine & Growth Factor Reviews, 67, 49–57. https://doi.org/10.1016/j.cytogfr.2022.07.004
   PubMed Web of Science ®Google Scholar
• Lowther, D. E., Goods, B. A., Lucca, L. E., Lerner, B. A., Raddassi, K., van Dijk, D., Hernandez, A. L., Duan, X., Gunel, M., Coric, V., Krishnaswamy, S., Love, J. C., & Hafler, D. A. (2016). PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight, 1(5), e85935. https://doi.org/10.1172/jci.insight.85935
   PubMed Web of Science ®Google Scholar
• Lugano, R., Ramachandran, M., & Dimberg, A. (2020). Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences, 77(9), 1745–1770. https://doi.org/10.1007/s00018-019-03351-7
   PubMed Web of Science ®Google Scholar
• Magill, S. T., Han, S. J., Li, J., & Berger, M. S. (2018). Resection of primary motor cortex tumors: Feasibility and surgical outcomes. Journal of Neurosurgery, 129(4), 961–972. https://doi.org/10.3171/2017.5.JNS163045
   PubMed Web of Science ®Google Scholar
• Ma, D., Liu, S., Lal, B., Wei, S., Wang, S., Zhan, D., Zhang, H., Lee, R. S., Gao, P., Lopez-Bertoni, H., Ying, M., Li, J. J., Laterra, J., Wilson, M. A., & Xia, S. (2019). Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in Glioblastoma. Cancer Research, 79(10), 2697–2708. https://doi.org/10.1158/0008-5472.CAN-18-3125
   PubMed Web of Science ®Google Scholar
• Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017). Tumour-associated macrophages as treatment targets in oncology. Nature Reviews, Clinical Oncology, 14(7), 399–416. https://doi.org/10.1038/nrclinonc.2016.217
   PubMed Web of Science ®Google Scholar
• Medikonda, R., Dunn, G., Rahman, M., Fecci, P., & Lim, M. (2021). A review of glioblastoma immunotherapy. Journal of Neuro-Oncology, 151(1), 41–53. https://doi.org/10.1007/s11060-020-03448-1
   PubMed Web of Science ®Google Scholar
• Mercurio, L., Ajmone-Cat, M. A., Cecchetti, S., Ricci, A., Bozzuto, G., Molinari, A., Manni, I., Pollo, B., Scala, S., Carpinelli, G., & Minghetti, L. (2016). Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model. Journal of Experimental & Clinical Cancer Research, 35(1), 55. https://doi.org/10.1186/s13046-016-0326-y
   PubMedGoogle Scholar
• Mestas, J., & Hughes, C. C. W. (2004). Immunology of mice and not men: Differences between mouse and human immunology. The Journal of Immunology, 172(5), 2731–2738. https://doi.org/10.4049/jimmunol.172.5.2731
   PubMed Web of Science ®Google Scholar
• Mo, F., Pellerino, A., Soffietti, R., & Ruda, R. (2021). Blood-brain barrier in brain tumors: Biology and clinical relevance. International Journal of Molecular Sciences, 22(23), 12654. https://doi.org/10.3390/ijms222312654
   PubMed Web of Science ®Google Scholar
• Mora, R., Abschuetz, A., Kees, T., Dokic, I., Joschko, N., Kleber, S., Geibig, R., Mosconi, E., Zentgraf, H., Martin‐Villalba, A., & Régnier‐Vigouroux, A. (2009). TNF-α- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia, 57(5), 561–581. https://doi.org/10.1002/glia.20785
   PubMed Web of Science ®Google Scholar
• Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J., Ivashkiv, L., Lawrence, T., Locati, M., Mantovani, A., Martinez, F., Mege, J.-L., Mosser, D., Natoli, G., Saeij, J., Schultze, J., … Vogel, S. (2014). Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity, 41(1), 14–20. https://doi.org/10.1016/j.immuni.2014.06.008
   PubMed Web of Science ®Google Scholar
• Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., Forsyth, P., Hattangadi-Gluth, J., Holdhoff, M., Horbinski, C., Junck, L., Kaley, T., Kumthekar, P., Loeffler, J. S., … Bergman, M. A. (2020). Central nervous system cancers, version 3.2020. Journal of the National Comprehensive Cancer Network, 18(11), 1537–1570. https://doi.org/10.6004/jnccn.2020.0052
   PubMed Web of Science ®Google Scholar
• Nakod, P. S., Kim, Y., & Rao, S. S. (2020). Three-dimensional biomimetic hyaluronic acid hydrogels to investigate glioblastoma stem cell behaviors. Biotechnology and Bioengineering, 117(2), 511–522. https://doi.org/10.1002/bit.27219
   PubMed Web of Science ®Google Scholar
• Nanta, R., Shrivastava, A., Sharma, J., Shankar, S., & Srivastava, R. K. (2019). Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells. Molecular and Cellular Biochemistry, 454(1–2), 11–23. https://doi.org/10.1007/s11010-018-3448-z
   PubMed Web of Science ®Google Scholar
• Noy, R., & Pollard, J. W. (2014). Tumor-associated macrophages: From mechanisms to therapy. Immunity, 41(1), 49–61. https://doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Pachocki, C. J., & Hol, E. M. (2022). Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma. Journal of Neuroinflammation, 19(1), 276. https://doi.org/10.1186/s12974-022-02630-8
   PubMed Web of Science ®Google Scholar
• Padfield, E., Ellis, H. P., & Kurian, K. M. (2015). Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma. Frontiers in Oncology, 5, 5. https://doi.org/10.3389/fonc.2015.00005
   PubMed Web of Science ®Google Scholar
• Pittet, M. J., Michielin, O., & Migliorini, D. (2022). Clinical relevance of tumour-associated macrophages. Nature Reviews, Clinical Oncology, 19(6), 402–421. https://doi.org/10.1038/s41571-022-00620-6
   PubMed Web of Science ®Google Scholar
• Platten, M., Kretz, A., Naumann, U., Aulwurm, S., Egashira, K., Isenmann, S., & Weller, M. (2003). Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas. Annals of Neurology, 54(3), 388–392. https://doi.org/10.1002/ana.10679
   PubMed Web of Science ®Google Scholar
• Pombo Antunes, A. R., Scheyltjens, I., Lodi, F., Messiaen, J., Antoranz, A., Duerinck, J., Kancheva, D., Martens, L., De Vlaminck, K., Van Hove, H., Kjølner Hansen, S. S., Bosisio, F. M., Van der Borght, K., De Vleeschouwer, S., Sciot, R., Bouwens, L., Verfaillie, M., Vandamme, N., … Van Ginderachter, J. A. (2021). Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nature Neuroscience, 24(4), 595–610. https://doi.org/10.1038/s41593-020-00789-y
   PubMed Web of Science ®Google Scholar
• Prabhu, A., Kesarwani, P., Kant, S., Graham, S. F., & Chinnaiyan, P. (2017). Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis. Neuro-Oncology, 19(12), 1599–1606. https://doi.org/10.1093/neuonc/nox100
   PubMed Web of Science ®Google Scholar
• Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., Setty, M., Leslie, C. S., Oei, Y., Pedraza, A., Zhang, J., Brennan, C. W., Sutton, J. C., Holland, E. C., Daniel, D., & Joyce, J. A. (2013). CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nature Medicine, 19(10), 1264–1272. https://doi.org/10.1038/nm.3337
   PubMed Web of Science ®Google Scholar
• Qin, W., Hu, L., Zhang, X., Jiang, S., Li, J., Zhang, Z., & Wang, X. (2019). The diverse function of PD-1/PD-L pathway beyond cancer. Frontiers in Immunology, 10, 2298. https://doi.org/10.3389/fimmu.2019.02298
   PubMed Web of Science ®Google Scholar
• Quail, D. F., Bowman, R. L., Akkari, L., Quick, M. L., Schuhmacher, A. J., Huse, J. T., Holland, E. C., Sutton, J. C., & Joyce, J. A. (2016). The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science, 352(6288), aad3018. https://doi.org/10.1126/science.aad3018
   PubMed Web of Science ®Google Scholar
• Rianna, C., Radmacher, M., Kumar, S., & Discher, D. (2020). Direct evidence that tumor cells soften when navigating confined spaces. Molecular Biology of the Cell, 31(16), 1726–1734. https://doi.org/10.1091/mbc.E19-10-0588
   PubMed Web of Science ®Google Scholar
• Roth, P., Silginer, M., Goodman, S. L., Hasenbach, K., Thies, S., Maurer, G., Schraml, P., Tabatabai, G., Moch, H., Tritschler, I., & Weller, M. (2013). Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain, 136(2), 564–576. https://doi.org/10.1093/brain/aws351
   PubMedGoogle Scholar
• Scott, D. W., & Gascoyne, R. D. (2014). The tumour microenvironment in B cell lymphomas. Nature Reviews Cancer, 14(8), 517–534. https://doi.org/10.1038/nrc3774
   PubMed Web of Science ®Google Scholar
• Seliger, C., Meyer, A. L., Leidgens, V., Rauer, L., Moeckel, S., Jachnik, B., Proske, J., Dettmer, K., Rothhammer-Hampl, T., Kaulen, L. D., Riemenschneider, M. J., Oefner, P. J., Kreutz, M., Schmidt, N.-O., Merrill, M., Uhl, M., Renner, K., Vollmann-Zwerenz, A., Proescholdt, M., & Hau, P. (2022). Metabolic heterogeneity of brain tumor cells of proneural and mesenchymal origin. International Journal of Molecular Sciences, 23(19), 11629. https://doi.org/10.3390/ijms231911629
   PubMed Web of Science ®Google Scholar
• Shao, Z., Tan, Y., Shen, Q., Hou, L., Yao, B., Qin, J., Xu, P., Mao, C., Chen, L.-N., Zhang, H., Shen, D.-D., Zhang, C., Li, W., Du, X., Li, F., Chen, Z.-H., Jiang, Y., Xu, H. E., … Zhang, Y. (2022). Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discovery, 8(1), 44. https://doi.org/10.1038/s41421-022-00403-4
   PubMed Web of Science ®Google Scholar
• Sharpe, A. H., & Pauken, K. E. (2018). The diverse functions of the PD1 inhibitory pathway. Nature Reviews, Immunology, 18(3), 153–167. https://doi.org/10.1038/nri.2017.108
   PubMed Web of Science ®Google Scholar
• Shin, D. H., Xuan, S., Kim, W. Y., Bae, G. U., & Kim, J. S. (2014). CD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cells. Journal of Materials Chemistry B, 2(24), 3771–3781. https://doi.org/10.1039/c4tb00185k
   PubMed Web of Science ®Google Scholar
• Stanley, E. R., & Chitu, V. (2014). CSF-1 receptor signaling in myeloid cells. Cold Spring Harbor Perspectives in Biology, 6(6), a021857–a021857. https://doi.org/10.1101/cshperspect.a021857
   PubMed Web of Science ®Google Scholar
• Takenaka, M. C., Gabriely, G., Rothhammer, V., Mascanfroni, I. D., Wheeler, M. A., Chao, C. C., Gutiérrez-Vázquez, C., Kenison, J., Tjon, E. C., Barroso, A., Vandeventer, T., de Lima, K. A., Rothweiler, S., Mayo, L., Ghannam, S., Zandee, S., Healy, L., Sherr, D., … Weiner, H. L. (2019). Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nature Neuroscience, 22(5), 729–740. https://doi.org/10.1038/s41593-019-0370-y
   PubMed Web of Science ®Google Scholar
• Tan, I. L., Arifa, R. D. N., Rallapalli, H., Kana, V., Lao, Z., Sanghrajka, R. M., Sumru Bayin, N., Tanne, A., Wojcinski, A., Korshunov, A., Bhardwaj, N., Merad, M., Turnbull, D. H., Lafaille, J. J., & Joyner, A. L. (2021). CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic hedgehog-medulloblastoma model. Oncogene, 40(2), 396–407. https://doi.org/10.1038/s41388-020-01536-0
   PubMed Web of Science ®Google Scholar
• Tap, W. D., Wainberg, Z. A., Anthony, S. P., Ibrahim, P. N., Zhang, C., Healey, J. H., Chmielowski, B., Staddon, A. P., Cohn, A. L., Shapiro, G. I., Keedy, V. L., Singh, A. S., Puzanov, I., Kwak, E. L., Wagner, A. J., Von Hoff, D. D., Weiss, G. J., Ramanathan, R. K., … Tong-Starksen, S. (2015). Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. The New England Journal of Medicine, 373(5), 428–437. https://doi.org/10.1056/NEJMoa1411366
   PubMed Web of Science ®Google Scholar
• Thaci, B., Ulasov, I. V., Ahmed, A. U., Ferguson, S. D., Han, Y., & Lesniak, M. S. (2013). Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Therapy, 20(3), 318–327. https://doi.org/10.1038/gt.2012.42
   PubMed Web of Science ®Google Scholar
• Tibbitt, M. W., & Anseth, K. S. (2009). Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnology and Bioengineering, 103(4), 655–663. https://doi.org/10.1002/bit.22361
   PubMed Web of Science ®Google Scholar
• Torrisi, F., D’Aprile, S., Denaro, S., Pavone, A. M., Alberghina, C., Zappala, A., Giuffrida, R., Salvatorelli, L., Broggi, G., Magro, G. G., Calabrese, V., Vicario, N., & Parenti, R. (2023). Epigenetics and metabolism reprogramming interplay into glioblastoma: Novel insights on immunosuppressive mechanisms. Antioxidants, 12(2), 220. https://doi.org/10.3390/antiox12020220
   Web of Science ®Google Scholar
• Truong, D., Fiorelli, R., Barrientos, E. S., Melendez, E. L., Sanai, N., Mehta, S., & Nikkhah, M. (2019). A three-dimensional (3D) organotypic microfluidic model for glioma stem cells – Vascular interactions. Biomaterials, 198, 63–77. https://doi.org/10.1016/j.biomaterials.2018.07.048
   PubMed Web of Science ®Google Scholar
• von Roemeling, C. A., Wang, Y., Qie, Y., Yuan, H., Zhao, H., Liu, X., Yang, Z., Yang, M., Deng, W., Bruno, K. A., Chan, C. K., Lee, A. S., Rosenfeld, S. S., Yun, K., Johnson, A. J., Mitchell, D. A., Jiang, W., & Kim, B. Y. S. (2020). Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nature Communications, 11(1), 1508. https://doi.org/10.1038/s41467-020-15129-8
   PubMed Web of Science ®Google Scholar
• Walentynowicz, K. A., Ochocka, N., Pasierbinska, M., Wojnicki, K., Stepniak, K., Mieczkowski, J., Ciechomska, I. A., & Kaminska, B. (2018). In search for reliable markers of glioma-induced polarization of microglia. Frontiers in Immunology, 9, 1329. https://doi.org/10.3389/fimmu.2018.01329
   PubMed Web of Science ®Google Scholar
• Wang, X., Ding, H., Li, Z., Peng, Y., Tan, H., Wang, C., Huang, G., Li, W., Ma, G., & Wei, W. (2022). Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Signal Transduction and Targeted Therapy, 7(1), 74. https://doi.org/10.1038/s41392-022-00894-3
   PubMed Web of Science ®Google Scholar
• Wang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., Barthel, F., Cho, H. J., Lin, Y.-H., Satani, N., Martinez-Ledesma, E., Zheng, S., Chang, E., Sauvé, C. E. G., … Nam, D.-H. (2017). Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell, 32(1), 42–56 e46. https://doi.org/10.1016/j.ccell.2017.06.003
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, D., Yang, L., & Zhang, Y. (2022). Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chinese Medical Journal, 135(20), 2405–2416. https://doi.org/10.1097/CM9.0000000000002426
   PubMed Web of Science ®Google Scholar
• Wang, S. C., Yu, C. F., Hong, J. H., Tsai, C. S., & Chiang, C. S. (2013). Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis. PLOSONE, 8(8), e69182. https://doi.org/10.1371/journal.pone.0069182
   PubMed Web of Science ®Google Scholar
• Wang, G., Zhong, K., Wang, Z., Zhang, Z., Tang, X., Tong, A., & Zhou, L. (2022). Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities. Frontiers in Immunology, 13, 964898. https://doi.org/10.3389/fimmu.2022.964898
   PubMed Web of Science ®Google Scholar
• Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L.-Y., Ling, X., Caruso, H., Zhou, S., Wang, Y. A., Fuller, G. N., Huse, J., Gilboa, E., Kang, N., Huang, X., Verhaak, R., Li, S., & Heimberger, A. B. (2019). Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. Journal of Clinical Investigation, 129(1), 137–149. https://doi.org/10.1172/JCI121266
   PubMed Web of Science ®Google Scholar
• Wischhusen, J., Friese, M. A., Mittelbronn, M., Meyermann, R., & Weller, M. (2005). HLA-E protects glioma cells from NKG2D-Mediated immune responses in vitro: implications for immune escape in vivo. Journal of Neuropathology & Experimental Neurology, 64(6), 523–528. https://doi.org/10.1093/jnen/64.6.523
   PubMed Web of Science ®Google Scholar
• Wolf, K. J., Chen, J., Coombes, J. D., Aghi, M. K., & Kumar, S. (2019). Dissecting and rebuilding the glioblastoma microenvironment with engineered materials. Nature Reviews Materials, 4(10), 651–668. https://doi.org/10.1038/s41578-019-0135-y
   PubMed Web of Science ®Google Scholar
• Xiao, W., Wang, S., Zhang, R., Sohrabi, A., Yu, Q., Liu, S., Ehsanipour, A., Liang, J., Bierman, R. D., Nathanson, D. A., & Seidlits, S. K. (2020). Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma. Matrix Biology, 85-86, 128–146. https://doi.org/10.1016/j.matbio.2019.04.003
   PubMed Web of Science ®Google Scholar
• Xiao, &., Wang, &., Zhao, &., Ji, &., Xiang, C., Li, T. (2022). A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma. Mathematical Biosciences and Engineering: MBE, 19(9), 9481–9504. https://doi.org/10.3934/mbe.2022441
   PubMed Web of Science ®Google Scholar
• Xuan, W., Lesniak, M. S., James, C. D., Heimberger, A. B., & Chen, P. (2021). Context-dependent glioblastoma–macrophage/microglia symbiosis and associated mechanisms. Trends in Immunology, 42(4), 280–292. https://doi.org/10.1016/j.it.2021.02.004
   PubMed Web of Science ®Google Scholar
• Yagi, T., Baba, Y., Okadome, K., Kiyozumi, Y., Hiyoshi, Y., Ishimoto, T., Iwatsuki, M., Miyamoto, Y., Yoshida, N., Watanabe, M., Komohara, Y., & Baba, H. (2019). Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. European Journal of Cancer (Oxford, England: 1990), 111, 38–49. https://doi.org/10.1016/j.ejca.2019.01.018
   PubMed Web of Science ®Google Scholar
• Yang, F., He, Z., Duan, H., Zhang, D., Li, J., Yang, H., Dorsey, J. F., Zou, W., Nabavizadeh, S. A., Bagley, S. J., Abdullah, K., Brem, S., Zhang, L., Xu, X., Byrne, K. T., Vonderheide, R. H., Gong, Y., & Fan, Y. (2021). Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nature Communications, 12(1), 3424. https://doi.org/10.1038/s41467-021-23832-3
   PubMed Web of Science ®Google Scholar
• Yan, D., Kowal, J., Akkari, L., Schuhmacher, A. J., Huse, J. T., West, B. L., & Joyce, J. A. (2017). Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. Oncogene, 36(43), 6049–6058. https://doi.org/10.1038/onc.2017.261
   PubMed Web of Science ®Google Scholar
• Yin, J., Kim, S. S., Choi, E., Oh, Y. T., Lin, W., Kim, T. H., Sa, J. K., Hong, J. H., Park, S. H., Kwon, H. J., Jin, X., You, Y., Kim, J. H., Kim, H., Son, J., Lee, J., Nam, D.-H., Choi, K. S., … Kim, J. H. (2020). ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nature Communications, 11(1), 2978. https://doi.org/10.1038/s41467-020-16789-2
   PubMed Web of Science ®Google Scholar
• Yin, J., Oh, Y. T., Kim, J. Y., Kim, S. S., Choi, E., Kim, T. H., Hong, J. H., Chang, N., Cho, H. J., Sa, J. K., Kim, J. C., Kwon, H. J., Park, S., Lin, W., Nakano, I., Gwak, H.-S., Yoo, H., Lee, S.-H., … Park, M.-J. (2017). Transglutaminase 2 inhibition reverses mesenchymal transdifferentiation of glioma stem cells by regulating C/EBPβ signaling. Cancer Research, 77(18), 4973–4984. https://doi.org/10.1158/0008-5472.CAN-17-0388
   PubMed Web of Science ®Google Scholar
• Yin, J., Valin, K. L., Dixon, M. L., & Leavenworth, J. W. (2017). The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer. Journal of Immunology Research, 2017, 5150678. https://doi.org/10.1155/2017/5150678
   PubMed Web of Science ®Google Scholar
• Zhai, K., Huang, Z., Huang, Q., Tao, W., Fang, X., Zhang, A., Li, X., Stark, G. R., Hamilton, T. A., & Bao, S. (2021). Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nature Cancer, 2(11), 1136–1151. https://doi.org/10.1038/s43018-021-00267-9
   PubMedGoogle Scholar
• Zhang, B., Peticone, C., Murthy, S. K., & Radisic, M. (2013). A standalone perfusion platform for drug testing and target validation in micro-vessel networks. Biomicrofluidics, 7(4), 44125. https://doi.org/10.1063/1.4818837
   PubMed Web of Science ®Google Scholar
• Zhao, Y., Qu, Y., Hao, C., & Yao, W. (2023). PD-1/PD-L1 axis in organ fibrosis. Frontiers in Immunology, 14, 1145682. https://doi.org/10.3389/fimmu.2023.1145682
   PubMed Web of Science ®Google Scholar
• Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S. (2015). Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nature Cell Biology, 17(2), 170–182. https://doi.org/10.1038/ncb3090
   PubMed Web of Science ®Google Scholar